This inventor holds 4 USPTO granted patents. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1993-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hannou, JP (1993 - 1994)
- Hanno, JP (1995)
Company Filing History:
Years Active: 1993-1995
Title: Innovations by Masahiro Suzuki: A Focus on Styrene and Isoxazole Derivatives
Introduction
Masahiro Suzuki, an accomplished inventor located in Hannou, Japan, has made significant contributions to the field of pharmaceuticals with his innovative research and development. With a total of four patents to his name, he focuses on advancing the science of chemical compounds, particularly in the realm of styrene and isoxazole derivatives.
Latest Patents
Among Masahiro Suzuki's latest patents are innovations related to styrene derivatives and salts thereof, as well as isoxazole derivatives and salts thereof. These patented technologies showcase his commitment to enhancing the pharmaceutical landscape and developing new compounds that can potentially lead to effective medical treatments.
Career Highlights
Masahiro Suzuki currently works at Taiho Pharmaceutical Company Limited, where he contributes his expertise and creativity towards groundbreaking research in the pharmaceutical industry. His work has been instrumental in the development of new drugs, and he has positioned himself as a valuable asset within his organization.
Collaborations
Throughout his career, Masahiro has collaborated with other notable professionals in the field, including Kenji Nozaki and Naohiko Ono. These partnerships have enabled him to combine knowledge and resources to foster innovation and advance their shared goals in pharmaceutical research.
Conclusion
Masahiro Suzuki is a prominent figure in the field of pharmaceutical inventions, with a strong focus on creating novel chemical compounds. His contributions through his patents and collaborative efforts continue to inspire advancements in medicine, solidifying his reputation as a leading inventor in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
